| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0198-8859(03)00041-7 |
| P698 | PubMed publication ID | 12691700 |
| P2093 | author name string | William C Chapman | |
| Andrés Jaramillo | |||
| T Mohanakumar | |||
| Mauricio Lisker-Melman | |||
| Jeffrey Crippin | |||
| Jayaprakash Sreenarasimhaiah | |||
| P2860 | cites work | Viral immune evasion due to persistence of activated T cells without effector function | Q24646943 |
| Cytokine-stimulated T cells induce macrophage IL-10 production dependent on phosphatidylinositol 3-kinase and p70S6K: implications for rheumatoid arthritis | Q24800148 | ||
| Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus | Q27469800 | ||
| Analysis of successful immune responses in persons infected with hepatitis C virus | Q27860698 | ||
| Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group | Q27861083 | ||
| Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C | Q29620791 | ||
| Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response | Q29620891 | ||
| Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 T cells in HCV infection | Q33916588 | ||
| B cells regulate autoimmunity by provision of IL-10. | Q34150590 | ||
| Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection | Q37359927 | ||
| Lymphocyte responses and cytokines | Q40620203 | ||
| Actions of cytokines on the immune response and viral interactions: an overview | Q41006613 | ||
| The treatment of chronic viral hepatitis | Q41332870 | ||
| Hepatitis C virus: epidemiology and transmission | Q41597495 | ||
| Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells | Q42941989 | ||
| Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study | Q42980410 | ||
| The cellular immune responses induced in the follow-up of interferon-alpha treated patients with chronic hepatitis C may determine the therapy outcome | Q42990947 | ||
| Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. | Q42997068 | ||
| Role of the specific T-cell response for clearance and control of hepatitis C virus | Q42998171 | ||
| Direct functional analysis of epitope-specific CD8+ T cells in peripheral blood. | Q43030593 | ||
| Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection | Q43031795 | ||
| Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients | Q43032962 | ||
| Lack of optimal T-cell reactivity against the hepatitis C virus is associated with the development of fibrosis/cirrhosis during chronic hepatitis | Q43042214 | ||
| The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection | Q45731185 | ||
| CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained | Q45740431 | ||
| Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I | Q45752944 | ||
| Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity | Q45764886 | ||
| Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile. | Q50587763 | ||
| The viral clearance in interferon-treated chronic hepatitis C is associated with increased cytotoxic T cell frequencies | Q72995509 | ||
| Hepatitis C | Q74751759 | ||
| P433 | issue | 5 | |
| P921 | main subject | ribavirin | Q421862 |
| Hepatitis C virus | Q708693 | ||
| chronic hepatitis C | Q55779873 | ||
| P304 | page(s) | 497-504 | |
| P577 | publication date | 2003-05-01 | |
| P1433 | published in | Human Immunology | Q15709955 |
| P1476 | title | Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-alpha and ribavirin treatment for chronic hepatitis C virus infection | |
| P478 | volume | 64 |
| Q45366434 | A prospective study of lymphocyte subpopulations and regulatory T cells in patients with chronic hepatitis C virus infection developing interferon-induced thyroiditis |
| Q37952808 | CCL5: a double-edged sword in host defense against the hepatitis C virus |
| Q26749249 | Cellular immune response to hepatitis-C-virus in subjects without viremia or seroconversion: is it important? |
| Q43033106 | Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C. |
| Q47675296 | Effects of interferon and ribavirin combination therapy on CD4+ proliferation, lymphocyte activation, and Th1 and Th2 cytokine profiles in chronic hepatitis C. |
| Q27486399 | Enhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-monoinfected individuals |
| Q42262339 | Hepatitis C virus-specific cellular immune responses in sustained virological responders with viral persistence in peripheral blood mononuclear cells |
| Q36967094 | IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin |
| Q46454510 | Immunomodulatory effects of selective leucocytapheresis as a new adjunct to interferon-alpha2b plus ribavirin combination therapy: a prospective study in patients with high plasma HCV viraemia |
| Q47594322 | Kinetics of soluble tumour necrosis factor (TNF)-alpha receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)-alpha alone, IFN-alpha plus amantadine or plus ribavirin |
| Q42984166 | Management of hepatitis C virus infection in liver transplantation with adacolumn apheresis |
| Q34896702 | Prediction of T-cell epitopes of hepatitis C virus genotype 5a |
| Q50575939 | Sustained virological response to peginterferon plus ribavirin in chronic hepatitis C genotype 1 patients is associated with a persistent Th1 immune response. |
| Q36968819 | Temporal association between increased virus-specific Th17 response and spontaneous recovery from recurrent hepatitis C in a liver transplant recipient |
Search more.